Shakudo enables pharmaceutical companies to streamline their drug development and FDA approval process by unifying clinical trial data, research findings, and regulatory documentation in one secure environment. Our platform integrates advanced AI tools that automate complex data mapping from multiple vendors and CROs, while maintaining strict HIPAA and regulatory compliance. Teams can deploy and manage these tools without specialized technical knowledge, allowing scientists and analysts to focus on drug development rather than data infrastructure.
Transform your drug development pipeline with an integrated AI platform that accelerates FDA approval timelines. This solution combines powerful data processing with AI-driven insights to streamline the path from clinical trials to market approval.
Snowflake and Dremio form the foundation for secure, compliant data storage and processing, while Neo4j creates knowledge graphs that connect complex relationships across clinical trials, research data, and regulatory requirements. Milvus powers similarity search across vast databases of chemical compounds and trial results, with LangChain orchestrating AI workflows that extract insights from unstructured medical documentation. Prometheus ensures system reliability with continuous monitoring of all components.
This integration drives faster FDA submissions by automating data preparation, reducing documentation errors, and providing real-time insights into trial progress. Quality teams can validate data integrity, researchers can quickly analyze trial results, and regulatory teams can generate required documentation - all from a single platform.
Building and maintaining this specialized stack traditionally requires 6-8 months of development and specialized DevOps expertise. With Shakudo, pharmaceutical companies can deploy these tools in days while maintaining complete control over their data and compliance requirements. Our platform provides the security and reliability of enterprise systems with the flexibility to adapt as regulatory requirements and AI capabilities evolve.